空間基因組學和轉錄組學市場規模、佔有率和成長分析：按服務類型、樣本類型、治療領域、應用、最終用戶和地區分類——2026-2033年行業預測

2024 年全球空間基因組學和轉錄組學市場價值為 4.274 億美元，預計到 2033 年將從 2025 年的 4.727 億美元成長至 10.5835 億美元，預測期（2026-2033 年）的複合年成長率為 10.6%。

受精準醫療需求和單細胞分析技術應用的推動，全球太空基因組學和轉錄組學市場正經歷顯著成長。推動這一成長的關鍵因素包括癌症和神經科學研究投入的增加、定序和成像平台的進步以及藥物研發應用的拓展。整個組織樣本進行DNA和RNA圖譜繪製的能力正在加速腫瘤學、發育生物學、神經科學和免疫學領域的研究，進一步推動市場成長。定序平台提供者、受託研究機構（CRO）和學術機構之間的夥伴關係正在創造新的商業化機會。然而，高成本、數據分析複雜、平台標準化過程緩慢以及樣本製備困難等挑戰可能會阻礙市場滲透。總而言之，對個人化醫療和基因組研究的需求正在推動這一充滿活力的市場格局。

全球空間基因組學和轉錄組學市場按產品、檢體類型、治療領域、應用、最終用戶和地區進行細分。按產品分類，市場分為儀器、耗材、軟體和分析以及服務。依檢體類型分類，市場分為活體冷凍組織、FFPE組織、固定冷凍組織、培養細胞和其他樣本。依治療領域分類，市場分為腫瘤學、神經病學、免疫學、感染疾病、心血管疾病和其他疾病。按應用分類，市場分為轉化研究、藥物發現與開發、臨床診斷研究、生物標記發現、細胞生物學研究和其他研究。按最終用戶分類，市場分為學術和研究機構、製藥和生物技術公司、合約研究組織（CRO）、臨床和診斷檢查室以及其他機構。依地區分類，市場分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球空間基因組學和轉錄組學市場的成長要素

全球空間基因組學和轉錄組學市場的主要驅動力之一是對個人化和精準醫療日益成長的需求。隨著醫學逐漸轉向基於個別基因和分子特徵的客製化治療方案，空間基因組學和轉錄組學為細胞和組織的空間組織提供了至關重要的見解。這項技術使研究人員和臨床醫生能夠更深入地了解疾病機制和異質性，從而加速標靶治療的開發。此外，成像技術和生物資訊學工具的進步提高了這些技術的可及性和適用性，使其在現代生物醫學研究和臨床實踐中發揮越來越重要的作用，進一步推動了市場成長。

全球空間基因組學和轉錄組學市場的限制因素

全球太空基因組學和轉錄組學市場的主要限制因素之一是空間分析所需的高級技術和設備的高成本。複雜的實驗流程、專業培訓的需求以及高級軟體的整合，對許多研究機構和實驗室而言，尤其是在發展中地區，都可能構成巨大的經濟障礙。此外，資料管理、隱私以及調查方法標準化等方面的擔憂也阻礙了這些技術的廣泛應用。這些經濟負擔往往限制了最尖端科技的普及，使其應用僅限於資金雄厚的機構，從而減緩了整體市場成長。

空間基因組學和轉錄組學市場的全球趨勢

全球太空基因組學和轉錄組學市場正經歷著由人工智慧驅動的分析技術融合所驅動的顯著成長趨勢。機器學習演算法和先進的計算方法正被擴大應用於從空間基因組學和轉錄組學資料集中提取有價值的資訊。這種方法不僅加速了生物標記的發現，也有助於更深入地理解組織結構內的細胞間相互作用。對模型可解釋性、雲端解決方案和精簡資料管道的關注加劇了空間生物學研究領域的競爭。因此，這一趨勢正在為臨床前研究中的預測建模鋪平道路，指導藥物標靶的識別，並加速數據分析和視覺化流程的最佳化。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球空間基因組學和轉錄組學市場規模：按產品/服務分類

• 裝置
• 消耗品
• 軟體分析
• 服務

全球空間基因組學和轉錄組學市場規模：按樣本類型分類

• 活體冷凍組織
• FFPE組織
• 固定/冷凍組織
• 培養細胞
• 其他

全球空間基因組學和轉錄組學市場規模：按治療領域分類

• 腫瘤學
• 神經病學
• 免疫學
• 感染疾病
• 心血管疾病
• 其他

全球空間基因組學和轉錄組學市場規模：按應用領域分類

• 轉化研究
• 藥物發現與開發
• 臨床診斷調查
• 生物標記發現
• 細胞生物學概覽
• 其他

全球空間基因組學和轉錄組學市場規模：按最終用戶分類

• 學術研究機構
• 製藥和生物技術公司
• 受託研究機構（CRO）
• 臨床和診斷檢查室
• 其他

全球空間基因組學和轉錄組學市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• 10x Genomics, Inc.
• Bruker Spatial Biology, Inc.
• Akoya Biosciences, Inc.
• Illumina, Inc.
• Bio-Techne Corporation
• Standard BioTools Inc.
• Revvity, Inc.
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Vizgen, Inc.
• Resolve Biosciences GmbH
• Ionpath, Inc.
• Parse Biosciences, Inc.
• STOmics Technology Co., Ltd.
• Molecular Instruments, Inc.
• Miltenyi Biotec BV & Co. KG
• Natera, Inc.
• Veracyte, Inc.
• Bionano Genomics, Inc.
• Seven Bridges Genomics Inc.

結論與建議

Global Spatial Genomics & Transcriptomics Market size was valued at USD 427.4 Million in 2024 and is poised to grow from USD 472.7 Million in 2025 to USD 1058.35 Million by 2033, growing at a CAGR of 10.6% during the forecast period (2026-2033).

The global market for spatial genomics and transcriptomics is experiencing significant growth driven by the demand for precision medicine and the adoption of single-cell analysis technologies. Key factors such as increased investment in cancer and neuroscience research, advancements in sequencing and imaging platforms, and expanding drug discovery applications are propelling this market forward. The ability to map DNA and RNA in whole tissue samples enhances research in oncology, developmental biology, neuroscience, and immunology, fostering further market growth. Collaborative partnerships among sequencing platform providers, contract research organizations, and academia are creating new commercialization opportunities. However, challenges including high instrument costs, complex data analysis, limited platform standardization, and sample preparation difficulties may impede market penetration. Overall, the need for personalized medicine and genomic research fuels this dynamic landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Spatial Genomics & Transcriptomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Spatial Genomics & Transcriptomics Market Segments Analysis

Global spatial genomics & transcriptomics market is segmented by offering, sample type, therapeutic area, application, end user,and region. Based on offering, the market is segmented into instruments, consumables, software &analytics,and services. Based on sample type, the market is segmented into fresh frozen tissue, FFPE Tissue, fixed frozen tissue, cultured cells,and others. Based on therapeutic area, the market is segmented into oncology, neurology, immunology, infectious diseases, cardiovasculardiseases,and others.Based on application, the market is segmented into translational research, drug discovery & development, clinical diagnostics research, biomarker discovery, cell biology research,and others. Based on end user, the market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations (CROs), clinical & diagnostic laboratories,and others. Based onregion, the market is segmented into North America, Europe, Asia Pacific, Latin America,and Middle East & Africa.

Driver of the Global Spatial Genomics & Transcriptomics Market

One key market driver for the Global Spatial Genomics & Transcriptomics Market is the increasing demand for personalized medicine and precision therapeutics. As healthcare shifts towards tailored treatment options based on individual genetic and molecular profiles, spatial genomics and transcriptomics provide crucial insights into the spatial organization of cells and tissues. This technology allows researchers and clinicians to better understand disease mechanisms and heterogeneity, facilitating the development of targeted therapies. Moreover, advancements in imaging technologies and bioinformatics tools are enhancing the accessibility and applicability of these techniques, further fueling market growth as they become integral to modern biomedical research and clinical practices.

Restraints in the Global Spatial Genomics & Transcriptomics Market

One of the key market restraints for the global spatial genomics and transcriptomics market is the high cost associated with the advanced technologies and equipment required for spatial analysis. The complex protocols, need for specialized training, and the integration of sophisticated software can pose significant financial barriers for many research institutions and laboratories, particularly in developing regions. Additionally, concerns regarding data management, privacy, and standardization of methodologies further hinder widespread adoption. The financial burden often restricts access to cutting-edge techniques, limiting their use to well-funded organizations and thereby slowing the overall growth of the market.

Market Trends of the Global Spatial Genomics & Transcriptomics Market

The Global Spatial Genomics and Transcriptomics market is witnessing a significant trend driven by the integration of AI-powered analytical techniques. Machine learning algorithms and advanced computational methods are increasingly being employed to extract valuable insights from spatial genomics and transcriptomics datasets. This approach not only accelerates biomarker discovery but also facilitates a deeper understanding of cellular interactions within tissue structures. The emphasis on model explainability, cloud-based solutions, and streamlined data pipelines is enhancing competitiveness in spatial biology research. Consequently, this trend is paving the way for predictive modeling in preclinical studies, guiding drug-target identification, and optimizing data analysis and visualization processes.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Spatial Genomics & Transcriptomics Market Size by Offering & CAGR (2026-2033)

• Market Overview
• Instruments
• Consumables
• Software & Analytics
• Services

Global Spatial Genomics & Transcriptomics Market Size by Sample Type & CAGR (2026-2033)

• Market Overview
• Fresh Frozen Tissue
• FFPE Tissue
• Fixed Frozen Tissue
• Cultured Cells
• Others

Global Spatial Genomics & Transcriptomics Market Size by Therapeutic Area & CAGR (2026-2033)

• Market Overview
• Oncology
• Neurology
• Immunology
• Infectious Diseases
• Cardiovascular Diseases
• Others

Global Spatial Genomics & Transcriptomics Market Size by Application & CAGR (2026-2033)

• Market Overview
• Translational Research
• Drug Discovery & Development
• Clinical Diagnostics Research
• Biomarker Discovery
• Cell Biology Research
• Others

Global Spatial Genomics & Transcriptomics Market Size by End User & CAGR (2026-2033)

• Market Overview
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Clinical & Diagnostic Laboratories
• Others

Global Spatial Genomics & Transcriptomics Market Size & CAGR (2026-2033)

• North America (Offering, Sample Type, Therapeutic Area, Application, End User)
  • US
  • Canada
• Europe (Offering, Sample Type, Therapeutic Area, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Offering, Sample Type, Therapeutic Area, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Offering, Sample Type, Therapeutic Area, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Offering, Sample Type, Therapeutic Area, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• 10x Genomics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Spatial Biology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akoya Biosciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Standard BioTools Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vizgen, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Resolve Biosciences GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ionpath, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parse Biosciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STOmics Technology Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Molecular Instruments, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec B.V. & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natera, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veracyte, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionano Genomics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seven Bridges Genomics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations